Latest in Hematology-Oncology
Reuters Health • The Doctor's Channel Daily Newscast
Iodine radioisotope therapy effective for bone metastases from thyroid cancer
1:35 |
Aug 15, 2011
|
Endocrinology, Hematology-Oncology, Oncology, Reuters Health • The Doctor's Channel Daily Newscast
NEW YORK (Reuters Health) – Most patients with differentiated thyroid cancer metastasized to bone benefit from iodine-131 therapy, with stabilization of disease and significant reduction in pain, a Chinese team reports in the Journal of Clinical Endocrinology and Metabolism for October.
Iodine-131 has...
Reuters Health • The Doctor's Channel Daily Newscast
Combining chemo with erlotinib no benefit in advanced lung cancer
1:31 |
Aug 12, 2011
|
Hematology-Oncology, Oncology, Reuters Health • The Doctor's Channel Daily Newscast
NEW YORK (Reuters Health) – Combining an EGFR-directed tyrosine kinase inhibitor with conventional chemotherapy does not seem to be a good treatment strategy for lung cancer. According to the results of a phase II trial, patients with advanced non-small-cell lung cancer (NSCLC) with tumor biomarkers...
Reuters Health • The Doctor's Channel Daily Newscast
Meta-analysis defines risk of congestive heart failure with sunitinib
1:48 |
Aug 8, 2011
|
Cardiology, Hematology-Oncology, Nephrology, Oncology, Pharmacists, Reuters Health • The Doctor's Channel Daily Newscast
NEW YORK (Reuters Health) – Pooled data suggest that cancer patients who are treated with sunitinib (Sutent; Pfizer) have about a 2-fold increased relative risk of developing high-grade congestive heart failure (CHF) and about a 3-fold increased risk of developing high-grade CHF. The absolute risks...
Bortezomib of uncertain benefit in therapy for follicular lymphoma
1:39
|
Aug 4, 2011
RF ablation alternative to surgery in early liver cancer
1:31
|
Aug 3, 2011
Radiosurgery may be better option for single brain metastasis
1:51
|
Aug 1, 2011
Epoetin cuts transfusion needs in acute leukemia, seems safe
1:46
|
Jul 29, 2011
No survival benefit to adjuvant chemo in older adults with stage II colon cancer
1:24
|
Jul 29, 2011
Chemotherapy sensitivity/resistance testing not ready for prime time
1:20
|
Jul 28, 2011
Occult lymph node metastasis does not impact breast cancer survival
2:10
|
Jul 28, 2011
GnRH agonist protects against chemo-induced premature ovarian failure
1:25
|
Jul 22, 2011
High-dose chemo with stem-cell transplant for breast cancer not worthwhile
1:18
|
Jul 20, 2011
Tandem stem-cell transplants for myeloma improve survival
1:47
|
Jul 7, 2011
Different comorbidities worsen breast cancer prognosis to differing degrees
1:26
|
Jul 6, 2011
Sunitinib may be helpful before nephrectomy in metastatic renal cancer
1:31
|
Jun 20, 2011
Tumor-derived vaccine improves survival in follicular lymphoma
1:42
|
Jun 2, 2011
Lung function tracks immunoglobulin replacement adequacy
1:24
|
Jun 1, 2011
Very small breast tumors may be highly aggressive
1:39
|
May 26, 2011
Gefitinib appropriate first-line agent for certain lung cancers
1:21
|
May 25, 2011
HPV and Cervical Cancer
2:05
|
May 25, 2011
Renal Artery Stentingt
1:31
|
May 25, 2011
High dose ursodeoxycholic acid tied to neoplasia in UC
1:17
|
May 24, 2011
Effectiveness of radiation therapy not jeopardized by amifostine use
1:23
|
May 18, 2011
Weight affects aromatase inhibitor efficacy in young breast cancer patients
1:20
|
May 12, 2011
